In this episode, hosts Nate Beaver and Kyle Faget examine the tension between federal and state authority in healthcare regulation. They explore when the FDA has the final say—and when states step in, highlighting real-world examples and legal implications for companies, counsel, and innovators navigating this evolving landscape.
All content for Real World Leadership is the property of The Vanguard Network and is served directly from their servers
with no modification, redirects, or rehosting. The podcast is not affiliated with or endorsed by Podjoint in any way.
In this episode, hosts Nate Beaver and Kyle Faget examine the tension between federal and state authority in healthcare regulation. They explore when the FDA has the final say—and when states step in, highlighting real-world examples and legal implications for companies, counsel, and innovators navigating this evolving landscape.
Just how valuable is the GC to the Board of Directors? Immeasurably, according to Deb Boyda. In fact, the GC holds the unique position of representing shareholder interests with a deep understanding of a business's inner workings. Listen to her insights into how a GC can become both trusted and invaluable to the Board.
Real World Leadership
In this episode, hosts Nate Beaver and Kyle Faget examine the tension between federal and state authority in healthcare regulation. They explore when the FDA has the final say—and when states step in, highlighting real-world examples and legal implications for companies, counsel, and innovators navigating this evolving landscape.
